WHO ICTRP trial
REAL world efficacy and safety analysis of pembrolizumab KEY truda
JPRN-UMIN000045538 · Japan Primary Registries Network (JPRN) · Recruiting
Key facts
| Trial ID | JPRN-UMIN000045538 |
|---|---|
| Public title | REAL world efficacy and safety analysis of pembrolizumab KEY truda |
| Scientific title | REAL world efficacy and safety analysis of pembrolizumab KEY truda - REAL-KEY trial |
| Primary sponsor | Tha Japan Lung Cancer Society |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Recruiting |
| Study type | Observational |
| Phase | Not selected |
| Countries | Japan |
| Conditions | Patients with non-small cell lung cancer |
| Registration date | Sep 30, 2021 |
| Target size | 1000 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: